Home/Filings/4/0001127602-13-023054
4//SEC Filing

ARIAD PHARMACEUTICALS INC 4

Accession 0001127602-13-023054

CIK 0000884731operating

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 5:19 PM ET

Size

9.5 KB

Accession

0001127602-13-023054

Insider Transaction Report

Form 4
Period: 2013-07-15
DODION PIERRE F
Senior VP, Chief Medical Off
Transactions
  • Exercise/Conversion

    Common Stock

    2013-07-15+16,00073,682 total
  • Exercise/Conversion

    Performance stock unit

    2013-07-1516,00016,000 total
    Common Stock (16,000 underlying)
  • Award

    Performance stock unit

    2013-07-15+32,00032,000 total
    Common Stock (32,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    0
Footnotes (3)
  • [F1]Shares were acquired upon vesting of performance share units awarded on March 20, 2012.
  • [F2]Each performance stock unit represents a right to receive one share of ARIAD common stock.
  • [F3]The performance stock units vest as to 50% of the award on 7/15/2013 and as to 25% on each of 7/15/2014 and 7/15/2015.

Issuer

ARIAD PHARMACEUTICALS INC

CIK 0000884731

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000884731

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:19 PM ET
Size
9.5 KB